Impilo's portfolio company Pelago Bioscience acquires RG Discovery
The deal combines Pelago's target engagement capabilities with RG Discovery's medicinal chemistry expertise, enabling full-cycle DMTA services for customers.
Latest Impilo News & Updates
See the latest news and media coverage for Impilo. We track all announcements, press releases, and industry mentions in real time, all in one place.
Nordic healthcare investment company
impilo.se- Headquarters
- Stockholm, Sweden
- Founded year
- 2017
- Company type
- Private company
- Number of employees
- 40–50
Last updated
Latest news about Impilo
In short: Impilo expanded its healthcare portfolio by closing Fund II at €700 million and completing key acquisitions, including Oticon Medical.
Company announcements
Impilo's portfolio company Pelago Bioscience acquires RG Discovery
The acquisition forms an integrated drug discovery partner spanning biology and chemistry.
Impilo and KKR announce strategic partnership in Immedica Pharma
KKR acquires Immedica, with Impilo reinvesting as equal owner. They support growth, Loargys launch, pipeline, and U.S. expansion.
Impilo completes acquisition of Oticon Medical
The deal from Demant A/S marks the first investment in Fund II.
Media coverage
Never miss news about Impilo
Track Impilo and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Impilo competitors & trending companies
Browse news for competitors to Impilo and other trending companies.
Malin
Allvida
Perpetua Medical
Flerie
MedCap
KDventures
Domyn
Mitsubishi Chemical Group
Teijin
Definium Therapeutics
SUNation
WIN Waste
Avient
Huntsman
Hexcel
Toray
Gurit
SGL Carbon
Ahlstrom
Park.Aero
Pantalones
Sakana AI
PartRunner
Power Integrations
Kroma
SocialLadder
CAMP
Wave
CardMedic
Bevz
InnerPlant
AgVend
Futuremood
Melboss
Geo-Solutions